We are live on
!
Find out more
TC
Trium Capital Portfolio holdings
AUM
$163M
Turnover
55%
1-Year Est. Return
45.8%
This Fund
S&P 500
This Quarter
Est. Return
+22.3%
1 Year Est. Return
+45.8%
3 Year Est. Return
+188.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$402M
AUM Growth
-$399M
(-50%)
Cap. Flow
+$130M
Cap. Flow
% of AUM
32.35%
Top 10 Holdings %
Top 10 Hldgs %
76.69%
Holding
80
New
25
Increased
14
Reduced
15
Closed
24
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.3
years
Top 20 Avg Time Held Equity + Options
0.3
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.3
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Canada ETF
EWC
|
+$67.1M |
| 2 |
SpringWorks Therapeutics
SWTX
|
+$35M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$26.3M |
| 4 |
Blueprint Medicines
BPMC
|
+$24.9M |
| 5 |
PlayAGS
AGS
|
+$22.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Paragon 28, Inc.
FNA
|
+$36.5M |
| 2 |
Enfusion, Inc.
ENFN
|
+$19.4M |
| 3 |
Paycor HCM, Inc. Common Stock
PYCR
|
+$18.2M |
| 4 |
SolarWinds Corporation Common Stock
SWI
|
+$17.9M |
| 5 |
Intra-Cellular Therapies Inc.
ITCI
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.16% |
| 2 | Healthcare | 23.89% |
| 3 | Consumer Staples | 8% |
| 4 | Consumer Discretionary | 5.79% |
| 5 | Industrials | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Nextpower Inc. Common Stock
NXT
$12.7B
| $205K | 0.05% |
3,763
-4,206
| -53% | -$211K |
2024 Q1
5 quarters
|
|
52
The Greenbrier Companies
GBX
$1.22B
| $164K | 0.04% |
+3,552
| New | +$159K |
2025 Q2
0 quarters
|
|
53
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$30.6B
| $97.9K | 0.02% |
173,500
| – | – |
2025 Q1
1 quarter
|
|
54
PUT
NVIDIA
NVDA
$5.25T
| $1.5K | ﹤0.01% |
30,000
| – | – |
2024 Q4
2 quarters
|
|
55
DELISTED
ESSA Bancorp
ESSA
| $388 | ﹤0.01% |
+20
| New | +$370 |
2025 Q2
0 quarters
|
|
56
DELISTED
Guaranty Bancshares
GNTY
| $42 | ﹤0.01% |
+1
| New | +$40 |
2025 Q2
0 quarters
|
|
57
AstraZeneca
AZN
$259B
| – | – |
-51,321
| Closed | -$7.54M | – |
|
58
Keel Infrastructure Corp
KEEL
$1.59B
| – | – |
-772,573
| Closed | -$609K | – |
|
59
First Busey Corp
BUSE
$2.42B
| – | – |
-3
| Closed | – | – |
|
60
Coeur Mining
CDE
$15.8B
| – | – |
-5
| Closed | – | – |
|
61
Cadeler
CDLR
$2.06B
| – | – |
-12,942
| Closed | -$254K | – |
|
62
PUT
DELISTED
Clearwater Analytics
CWAN
| – | – |
-375,300
| Closed | -$10.1M | – |
|
63
Darling Ingredients
DAR
$9.61B
| – | – |
-17,107
| Closed | -$534K | – |
|
64
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| – | – |
-93,705
| Closed | -$685K | – |
|
65
Sabesp
SBS
$22B
| – | – |
-223,097
| Closed | -$773K | – |
|
66
Vitesse Energy
VTS
$733M
| – | – |
-4
| Closed | – | – |
|
67
DELISTED
Markforged Holding Corporation
MKFG
| – | – |
-403,489
| Closed | -$1.89M | – |
|
|
68
DELISTED
Enfusion, Inc.
ENFN
| – | – |
-1,739,870
| Closed | -$19.4M | – |
|
|
69
DELISTED
Paragon 28, Inc.
FNA
| – | – |
-2,795,307
| Closed | -$36.5M | – |
|
70
DELISTED
Chimerix, Inc.
CMRX
| – | – |
-544,153
| Closed | -$4.63M | – |
|
71
DELISTED
Altus Power
AMPS
| – | – |
-305,462
| Closed | -$1.51M | – |
|
|
72
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| – | – |
-810,746
| Closed | -$18.2M | – |
|
|
LGTY
73
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| – | – |
-99,259
| Closed | -$1.42M | – |
|
74
DELISTED
NEVRO CORP.
NVRO
| – | – |
-778,990
| Closed | -$4.55M | – |
|
|
75
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-102,105
| Closed | -$13.5M | – |
|
Similar funds
VVM
GF
ACM
KFS
VB
RWA
CCM
CFG
Trium Capital's Q2 2025 Portfolio in Review
As of Q2 2025, Trium Capital held 80 positions worth $402M, down 50% from $801M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
Trium Capital deployed $130M of net new capital in Q2 2025, opening 25 new positions and adding to 14 existing holdings. Its largest new stake was iShares MSCI Canada ETF: 1,552,508 shares worth $71.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 76% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Trane Technologies, an estimated $808K trimmed.
- Trium Capital's largest Q2 2025 buy was iShares MSCI Canada ETF: 1,552,508 shares worth $71.7M.
- Trium Capital added most to KraneShares CSI China Internet ETF in Q2 2025, an estimated $1.94M increase.
- Trium Capital's biggest Q2 2025 reduction was Trane Technologies, cutting an estimated $808K.
- Trium Capital fully exited Paragon 28, Inc. in Q2 2025, selling an estimated $36.5M.
- Trium Capital's ten largest holdings make up 77% of its $402M portfolio in Q2 2025.
- Trium Capital opened 25 new positions and closed 24 in Q2 2025.
- Trium Capital's portfolio value fell 50% quarter-over-quarter to $402M.
Based on Trium Capital's 13F filing for Q2 2025, filed 11 Aug 2025.